Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Letter]

Affiliations

¹ Department of Oncology, Beilun Branch of the First Affiliated Hospital, College of Medicine, Zhejiang University, Ningbo, 315826, People's Republic of China.

Kailang Li. J Inflamm Res. 2025.

. 2025 Jun 27:18:8525-8526.

doi: 10.2147/JIR.S542961. eCollection 2025.

¹ Department of Oncology, Beilun Branch of the First Affiliated Hospital, College of Medicine, Zhejiang University, Ningbo, 315826, People's Republic of China.

No abstract available

Conflict of interest statement

The author declares no conflict of interest in this communication.

1. Yu Q, Sun Y, Zhang S, et al. Predictive value of advanced lung cancer inflammation index and development of a nomogram for prognosis in patients with cervical cancer treated with radiotherapy. J Inflamm Res. 2025;18:5371–5382. doi: 10.2147/jir.S501513 - DOI - PMC - PubMed
1. Lorusso D, Xiang Y, Hasegawa K, et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, Phase 3 trial. Lancet. 2024;404:1321–1332. doi: 10.1016/s0140-6736(24)01808-7 - DOI - PubMed
1. Abu-Rustum NR, Yashar CM, Arend R, et al. NCCN guidelines^® insights: cervical cancer, version 1.2024. J Natl Compr Cancer Netw. 2023;21:1224–1233. doi: 10.6004/jnccn.2023.0062 - DOI - PubMed
1. Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330:547–558. doi: 10.1001/jama.2023.13174 - DOI - PubMed
1. Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21:1643–1648. doi: 10.1016/j.spinee.2021.02.024 - DOI - PMC - PubMed